retatrutide type 2 diabetes phase 2 weight loss 2024 What caught my attention wasn't just the number. It was what the number represents. New 3 trial data for showed an average of 28.3% at the highest dose Retatrutide study sees significant weight

In the study, there was a statistically significant 24% relative risk reduction in the combined endpoint of kidney disease worsening, kidney failure, and death due to cardiovascular disease compared to placebo after three years, when added to standard of care

Peery AF et al

Estaba escribiendo una tesis de maestra sobre los frmacos GLP-1

10.1126/science.1218595 115 JennisM.KungC

Month One to Three: Visible Weight Loss Begins For many patients, months one through three are when visible results become more apparent

There are various factors that determine the expression of these genes, such as the interaction of other genes, lifestyle choices, and interventions